Charles Rosser

Credentials: · · · · · · ·

History

A Multiplex Protein Biomarker-Based Immunoassay for the Early Detection of Bladder Cancer and Its Implications in Tumor Biology
National Cancer Institute · R01
Contact PI · $1.6M · Cedars-Sinai Medical Center
2023–2028
Multiplexed Protein Biomarker-Based Assay for the Detection of Bladder Cancer
National Cancer Institute · R01
Contact PI · $6.8M · Cedars-Sinai Medical Center
2016–2027
Application of a Multiplexed Immunoassay for the Detection of Bladder Cancer
National Cancer Institute · UH3
Contact PI · $1.2M · Cedars-Sinai Medical Center
2022–2025
University of Hawaii Cancer Center CCSG
National Cancer Institute · P30
Project lead · $749.7K · University of Hawaii at Manoa
2023

Radiogenomics of Muscle Invasive Bladder Cancer
Principal investigator · Terminated
Cedars-Sinai Medical Center
2021–2024
Isoflavone in Prostate-specific Antigen Recurrent Prostate Cancer
Principal investigator · Completed · Phase 2
University of Florida
2003–2007
Predicting BCG Response
Study director · Recruiting
Cedars-Sinai Medical Center
2020–2030
A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Cancer
Study director · Active not recruiting
Cedars-Sinai Medical Center
2016–2026